By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nippon Shinyaku Co., Ltd. 

14 Nishinosho-Monguchi-cho
Kisshoin, Minami-ku
Kyoto    601-8550  Japan
Phone: 075-321-1111 Fax: 075-321-0678



Company News
Jazz Pharma (JAZZ) And Nippon Shinyaku Co., Ltd. Enter Into License Agreements For The Development And Commercialization Of Defitelio And Vyxeos In Japan 3/30/2017 6:36:15 AM
Nippon Shinyaku Co., Ltd. Selects and Deploys the Symyx Technologies, Inc. (SMMX) Notebook by Accelrys Inc. (ACCL) 11/9/2011 10:01:50 AM
Labopharm (DDS.TO), Nippon Shinyaku Co., Ltd. Reach Licensing Deal 4/8/2010 8:16:47 AM
Pharmion Corporation (PHRM) And Nippon Shinyaku Co., Ltd. Announce Licensing Agreement For Vidaza(R) In Japan 11/21/2006 10:06:45 AM
Bayer Yakuhin Ltd. To Transfer Baynas Marketing Rights To Nippon Shinyaku Co., Ltd. 4/24/2006 10:56:52 AM
Nippon Shinyaku Co., Ltd. And Innovive Pharmaceuticals, Inc. Conclude Licensing Agreement For NS-187, Drug Candidate For Chronic Myelogenous Leukemia 1/6/2006 10:38:14 AM
Hisamitsu Pharmaceutical , Nippon Shinyaku Co., Ltd. Conclude Joint Development Agreement For HFT-290 Cancer Pain Palliative Care Agent10/19/2005 5:13:14 PM
AEterna Zentaris (AEZS) Announces Decision To Continue Cetrorelix Development In Benign Prostate Hyperplasia In Japan10/19/2005 5:13:03 PM
Nippon Shinyaku Co., Ltd., Janssen Pharmaceutica Products, L.P. , Grunenthal GmbH To Collaborate In Development Of Oral Analgesic In Japan10/19/2005 5:12:47 PM
Cell Therapeutics, Inc. (CTIC) Release: TRISENOX(R) Now Available To APL Patients In Japan After Nippon Shinyaku Co., Ltd. Launch10/19/2005 5:12:24 PM